Penicillin-Binding Proteins in Streptococcus agalactiae and Their Association with Reduced Penicillin Susceptibility:

Leonardo Nagao Ferreira1, Bruna Alves Pimentel Hecht2, Louisy Sanches Dos Santos3

  • 1Souza Marques Technical Education Foundation, Souza Marques School of Medicine, Rio de Janeiro 22793-140, RJ, Brazil.

PubMed

Insights

Antimicrobial resistance is a growing threat. This review highlights increasing penicillin resistance in Streptococcus agalactiae, driven by changes in penicillin-binding proteins, necessitating enhanced monitoring and control measures.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Streptococcus agalactiae causes serious infections, with antimicrobial resistance posing a global public health risk.
  • Penicillin is the primary treatment for invasive S. agalactiae infections, but resistance is emerging worldwide.
  • Penicillin-binding proteins (PBPs), particularly PBP2X, are implicated in reduced susceptibility to beta-lactams in streptococci.

Purpose of the Study:

  • To review current data on penicillin-binding proteins in S. agalactiae.
  • To summarize trends in penicillin susceptibility and resistance in S. agalactiae.
  • To highlight the increasing prevalence of penicillin-resistant strains.

Main Methods:

  • Literature review of published data.
  • Analysis of studies reporting on penicillin-binding proteins and penicillin susceptibility in S. agalactiae.
  • Identification of geographical distribution of resistant strains.

Main Results:

  • Penicillin-binding protein PBP2X is associated with reduced susceptibility to beta-lactams in S. agalactiae.
  • Increasing numbers of S. agalactiae strains exhibit reduced susceptibility and resistance to penicillin.
  • High levels of penicillin resistance in invasive S. agalactiae have been reported in Japan, the US, Canada, and Africa.

Conclusions:

  • Emerging penicillin resistance in S. agalactiae is a significant concern.
  • Increased monitoring of S. agalactiae strains with reduced penicillin susceptibility is crucial.
  • Preventive measures are needed to control the spread of resistant strains.

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
551
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.8K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
648